학술논문

IBCL-117 ASPEN: Long-Term Follow-Up Results of a Phase 3 Randomized Trial of Zanubrutinib vs Ibrutinib in Patients With Waldenström Macroglobulinemia
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S385-S385
Subject
Language
ISSN
2152-2650